Featured Articles
The popular press has only recently begun to appreciate the growing threat posed by antibiotic resistant bacteria (1,2). According to the Infectious Disease Society of America over 70% of hospital-acquired infections in the United States are resistant to one or more antibiotics. A single resistant bacterial pathogen, Methicillin-resistant Staphylococcus aureus caused 18,964 mortalities in the United States in 2006 alone (3). This is particularly worrisome, as the repertoire of compounds in our arsenal to tackle this threat has remained stagnant.











